From: Dr. James Coleman [info@cancerresearchamerica.org]
Sent: Wednesday, October 29, 2003 3:45 PM
To: fdadockets@oc.fda.gov
Subject: FDA Citizens' Petition, Docket Number 99P-1340

To: FDA

From: James W. Coleman, Ph.D.

Subject: FDA Citizens' Petition, Docket Number 99P-1340


Dear Madame or Sir:

This letter comes in support of the above-referenced Petition seeking to have warning labels placed on cosmetics.   In the interest of public health, I believe the FDA has an affirmative duty to take steps to make it required under the law to have warning labels on cosmetics for the reasons enumerated below.
  1.. It is well documented that ingredients in many cosmetics in widespread use by girls and women are carcinogenic and estrogenic and, therefore, potentially harmful. 
  2.. Cosmetics have been shown in mainstream medical and scientific journals to have positive associations with breast cancer and other illnesses, including fatal non-Hodskins lymphoma and multiple myeloma.  See my article at this link: http://www.CancerResearchAmerica.org/cosmetics.html 
  3.. A significant number of people develop asthma attacks and as a result some go into anaphylactic shock or cardiac arrest upon expose to perfumes. 
  4.. Fragrances in cosmetics are known to adversely affect the autonomic nervous and cardiovascular systems, leading to dangerously high or low blood pressure readings. 
  5.. Many people have developed a severe medical condition known as Multiple Chemical Sensitivities after being exposed to cosmetics or fragranced products. 
  6.. Women are urged to read labels but some of the existing chemical names on the labels are highly technical and, hence, meaningless to many women.   Most people can relate to the word "Warning."
Finally, I hereby request that this letter be filed and posted on the Internet in association with said Petition.

Sincerely yours,

s/James W. Coleman, Ph.D.
President/CEO
Cancer Research Center of America, Inc.
8622 Blackpool Drive
Louisville, KY 40222

(502) 339-1282
Fax (502) 339-1134